Lentiviral Vector Production Services

Lentiviral vector gene therapy is used extensively in advanced clinical trials and regulatory-approved therapies due to its scalable and cost-effective manufacturing platforms. Bringing innovative lentiviral vector manufacturing platform solutions to its partners globally, Andelyn Biosciences’ expertise supports preclinical studies through Phase III

Leverage our experience in lentiviral production today

What to Look for in a Viral Vector CDMO Partner

Andelyn Biosciences provides high-quality lentiviral vectors for preclinical research studies, toxicology studies through Phase III clinical studies. Our suspension-based or adherent platforms provide reliability, scalability and flexibility to your process.

 

Why Partner With Andelyn Biosciences?

With over 20 years of experience in viral vector manufacturing, Andelyn Biosciences’ platform manufacturing capabilities are paired with a mission to provide life-changing  therapies for incurable diseases as well as rare disorders. By partnering with Andelyn Biosciences you ensure reliability, scalability and platform expertise to accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.